I’ll show you small cell lung cancer.
Small cell lung cancer (SCLC) is a highly malignant lung cancer type, known for its rapid growth, early transfer and poor prognosis. This cancer originates in bronchial mucous membranes or glands, which account for about 15-20 per cent of all lung cancers and most patients are in the middle and late stages of diagnosis. This paper will explore four aspects: the description of small-cell lung cancer, the path to detection, the challenge of treatment and psychological care. 1. The description of small cell lung cancer is characterized by the unique morphological characteristics of tumour cells with small cell lung cancer, including the scarcity of plasma, unclear cell boundaries, nucleotochrome granular form, non-nucleus or non-observed. These cells are usually rounded, egg rounded or shuttled, with visible nucleus, widespread depravity and high levels of nuclear fragmentation. These characteristics make small-cell lung cancer easily identifiable under the microscope, but also presage its high levels of intrusive and malignantity. Small-cell lung cancer is growing at a very high rate, often in a short period of time, forming larger tumour blocks and rapidly immersing and shifting to the surrounding tissues. This rapid growth and transfer properties make the treatment of small-cell lung cancer particularly difficult, and patients tend to have poor prognosis. The early detection of small cell lung cancer is essential for improving the efficacy of treatment and extending the life of the patient. At present, small-cell lung cancer is detected mainly by: When pulmonary cancer is suspected in X-rays, a more in-depth examination should be carried out in a timely manner. Chest CT: CT is the most important and commonly used method of video screening for the diagnosis, phasing, efficacy evaluation and post-treatment diagnosis of lung cancer. It can show hard-to-discover video information on X-ray chests, effectively detect early lung cancer, and determine the extent and extent of the disease. (b) Cellological testing: this is a simple, unsolved method that is easily accessible to patients. A preliminary determination of the presence of lung cancer can be made by examining the fall cells in the sap. This method can also be used as a screening tool for populations at high risk of lung cancer. Pneumocular examination: For patients suspected of lung cancer, bronchoscopy provides a more direct and accurate basis for diagnosis. Through bronchial lenses, doctors can visualize the position, morphology and size of the tumor and obtain tissue samples for pathological diagnosis. Third, the treatment of small cell lung cancer is challenging. The high degree of depravity and rapid growth make it difficult for treatment to achieve satisfactory results. At present, the treatment of small-cell lung cancer includes, inter alia, chemotherapy, treatment of discharge, surgery and immunotherapy. Chemotherapy: Small cell lung cancer is very sensitive to chemotherapy, so chemotherapy is the preferred way to treat small cell lung cancer. However, due to the rapid growth and drug resistance of tumour cells, chemotherapy is often limited and prone to relapse. Demobilization: The demobilization is mainly used to partially control the growth of tumours and to mitigate symptoms. For small-cell lung cancer of limited duration, the effects of the treatment can be better. However, for a wide range of small cell lung cancers, the effect of the treatment is relatively poor. Surgery: The operation is mainly for the treatment of early small-cell lung cancer. However, due to the high degree of malignity of small cell lung cancer and its susceptibility to diversion, there are often limited opportunities for surgery. Immunization treatment: In recent years, some progress has been made in the treatment of small-cell lung cancer. However, because of the complexity of the micro-immunization environment for small-cell lung cancer, the effectiveness of immunization treatment varies from person to person. Psychiatry for small-cell lung cancer The severity and poor prognosis of small-cell lung cancer has placed enormous stress and burden on patients. Psychological care is therefore particularly important in the treatment of small-cell lung cancer. Building trust relationships: Medical personnel should establish a good relationship of trust with patients, listen to patient complaints and concerns, and provide positive responses and comfort. Provision of psychological support: Helping patients to alleviate negative emotions such as anxiety, fear and depression through psychological counselling and counselling, and improving their psychological resilience and quality of life. Strengthening family support: Family members should provide adequate care and support to patients and accompany them through difficult times. At the same time, family members should be informed about small-cell lung cancer in order to better care for patients. (b) Rehabilitation guidance: During and after treatment, medical personnel shall provide rehabilitation guidance, including advice on eating, exercise, rest, etc., to help the patient to recover his/her physical function and improve the quality of life. In summary, small-cell lung cancer is a highly malignant lung cancer type and its treatment is extremely challenging. However, through scientific screening, accurate diagnosis, effective treatment and comprehensive psychological care, we can provide better treatment and quality of life for patients. In the future, as medical technology continues to improve and scientific research continues, we have reason to believe that small cell lung cancer can be cured.
